MICA and cytomegalovirus infection: In addition, the donor MICA rs2596538 G allelic variant is a prospective protective prediction marker for CMV infection after transplantation potentially allowing the future development of individually tailored CMV therapy approaches for this genetically predisposed patient cohort.